Cardio Diagnostics (CDIO)

• Market cap: $39.4M
• 1 day: -4.53%
• 5 days: -30.44%
• 1 month: 298.77%
• 3 months: 247.79%
• 6 months: 95.82%
• Year to date: -68.18%
• 1 year: -55.53%
• 5 years: -74.51%
• 10 years: -74.51%
• Sector: Healthcare
• Industry: In Vitro & In Vivo Diagnostic Substances

About: Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.

Employees: 9

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

1.5% less ownership

Funds ownership: 7.98% [Q2] → 6.48% (-1.5%) [Q3]

6% less funds holding

Funds holding: 16 [Q2] → 15 (-1) [Q3]

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

62% less capital invested

Capital invested by funds: $996K [Q2] → $374K (-$622K) [Q3]